Ruthenium(III) maltolato-nitroimidazole complexes: Synthesis and biological activity

Journal of Inorganic Biochemistry

Volumn 100, Issue 12, 2006, Pages 1974-1982

  Kennedy, David C ^a   Wu, Adam ^a   Patrick, Brian O ^a   James, Brian R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Crystal structures; Fluorinated nitroimidazoles; Maltolato ligands; MTT assay; Nitroimidazoles; Ruthenium complexes

Indexed keywords

2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; 2 (3 NITRO 1H TRIAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACETAMIDE DERIVATIVE; METRONIDAZOLE; N (2,2,3,3,3 PENTAFLUOROPROPYL)CHLOROACETAMIDE; NITROIMIDAZOLE DERIVATIVE; PHOSPHATE BUFFERED SALINE; RUTHENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CONDUCTANCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYCLIC POTENTIOMETRY; DRUG SYNTHESIS; DRUG UPTAKE; HUMAN; HUMAN CELL; IC 50; INFRARED RADIATION; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; X RAY CRYSTALLOGRAPHY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CRYSTALLOGRAPHY, X-RAY; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; IMIDAZOLES; MAGNETIC RESONANCE SPECTROSCOPY; ORGANOMETALLIC COMPOUNDS;

EID: 33750932526     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2006.07.001     Document Type: Article

References (38)

1. Adams G.E., Flockhart I.R., Smithen C.E., Stratford I.J., Wardman P., and Watts M.E. Radiat. Res. 67 (1976) 9-20
2. Chapman J.D., Lee J., and Meeker B.E. In: Adams G.E., Breccia A., Fielden E.M., and Wardman P. (Eds). Selective Activation of Drugs by Redox Processes (1990), Plenum Press, New York 313-324
3. Evans S.M., Hahn S., Pook D.R., Jenkins W.T., Chalian A.A., Zhang P., Stevens C., Weber R., Weinstein G., Benjamin I., Mirza N., Morgan M., Rubin S., McKenna W.G., Lord E.M., and Koch C.J. Cancer Res. 60 (2000) 2018-2024
4. Fowler J.F., and Denekamp J. Pharmacol. Therapeut. 7 (1979) 413-444
5. Hodgkiss R.J. Anti-Cancer Drug Des. 13 (1998) 687-702
6. Cohen-Jonathan E., Evans S.M., Koch C.J., Muschel R.J., McKenna W.G., Wu J., and Bernhard E.J. Cancer Res. 61 (2001) 2289-2293
7. Wardman P. Environ. Health Perspect. 64 (1985) 309-320
8. Berger M.R., Garzon F.T., Keppler B.K., and Schmahl D. Anticancer Res. 9 (1989) 761-765
9. Frausin F., Cocchietto M., Bergamo A., Scarcia V., Furlani A., and Sava G. Cancer Chemother. Pharmacol. 50 (2002) 405-411
10. Keppler B.K., Balzer W., and Seifried V. Arzneimittel Forschung (Drug Res.) 37 (1987) 770-771
11. Galeano A., Berger M.R., and Keppler B.K. Arzneimittel Forschung (Drug Res.) 42 (1992) 821-824
12. Keppler B.K., Rupp W., Juhl U.M., Endres H., Niebl R., and Balzer W. Inorg. Chem. 26 (1987) 4366-4370
13. Keppler B.K., Wehe D., Endres H., and Rupp W. Inorg. Chem. 26 (1987) 844-846
14. Sava G., and Bergamo A. Int. J. Oncol. 17 (2000) 353-365
15. Sava G., Capozzi I., Clerici K., Gagliardi G., Alessio E., and Mestroni G. Clin. Expt. Metastasis 16 (1998) 371-379
16. Sava G., Pacor S., Coluccia M., Mariggio M., Cocchietto M., Alessio E., and Mestroni G. Drug Invest. 8 (1994) 150-161
17. Aird R.E., Cummings J., Ritchie A.A., Muir M., Morris R.E., Chen H., Sadler P.J., and Jodrell D.I. Br. J. Cancer 86 (2002) 1652-1657
18. Allardyce C.S., Dyson P.J., Ellis D.J., and Heath S.L. Chem. Commun. (2001) 1396-1397
19. Huxham L.A., Cheu E.L.S., Patrick B.O., and James B.R. Inorg. Chim. Acta 352 (2003) 238-246
20. Morris R.E., Arid R.E., Murdoch P.S., Chen H., Cummings J., Hughes N.D., Parsons S., Parkin A., Boyd G., Jodrell D.I., and Sadler P.J. J. Med. Chem. 44 (2001) 3616-3621
21. Velders A.H., Kooijman H., Spek A.L., Haasnoot J.G., de Vos D., and Reedijk J. Inorg. Chem. 39 (2000) 2966-2967
22. Wu A., Kennedy D.C., Patrick B.O., and James B.R. Inorg. Chem. 42 (2003) 7579-7586
23. Wu A., Kennedy D.C., Patrick B.O., and James B.R. Inorg. Chem. Commun. 6 (2003) 996-1000
24. Kennedy D.C., Wu A., Patrick B.O., and James B.R. Inorg. Chem. 44 (2005) 6529-6535
25. I.R. Baird, Fluorinated Nitroimidazoles and Their Complexes: Potential Hypoxia-imaging Agents, Ph.D. Dissertation, University of British Columbia, Vancouver, 1999.
26. Baird I.R., Skov K.A., James B.R., Rettig S.J., and Koch C.J. Synth. Commun. 28 (1998) 3701-3709
27. Gordon A.J., and Ford R.A. The Chemist's Companion: A Handbook of Practical Data, Techniques, and References (1972), John Wiley & Sons Inc, New York
28. Pavia D.L., Lampman G.M., and Kriz G.S. Introduction to Spectroscopy. second ed. (1996), Harcourt Brace & Company, Orlando
29. Geary W.J. Coord. Chem. Rev. 7 (1971) 81-122
30. *TREK, Area Detector Software, Version 7.11, Molecular Structure Corporation, The Woodlands, TX, 2001.
31. Altomare A., Cascarano M., Giacovazzo C., and Guagliardi A. J. Appl. Cryst. 26 (1993) 343-350
32. Anderson C. Can. J. Chem. 79 (2001) 1477-1482
33. Anderson C., and Beauchamp A.L. Can. J. Chem. 72 (1995) 471-482
34. Anderson C., and Beauchamp A.L. Inorg. Chem. 34 (1995) 6065-6073
35. Domingues M.R.M., Santana-Marques M.G.O., Domingues P., Neves M.G., Cavaleiro J.A., Ferrer-Correia A.J., Nemirovsky O.V., and Gross M.L. J. Am. Soc. Mass Spectrom. 12 (2001) 381-384
36. McLafferty F.W., and Turecek F. Mass Spectrometry Interpretation of Mass Spectra. fourth ed. (1993), University Science Books, Mill Valley, Sausalito
37. McMurray J. Organic Chemistry. third ed. (1992), Brooks/Cole Publishing Company, Pacific Grove, CA
38. Bard A.J., and Faulkner L.R. Electrochemical Methods - Fundamentals (1980), John Wiley, New York